We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$80.5B
AUM Growth
-$3.46B
(-4.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
13.64%
Holding
817
New
51
Increased
266
Reduced
358
Closed
117
Avg Time Held
3.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$499M |
| 2 |
Fidelity National Information Services
FIS
|
+$462M |
| 3 |
Honeywell
HON
|
+$367M |
| 4 |
Lennar Class A
LEN
|
+$321M |
| 5 |
Extra Space Storage
EXR
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$486M |
| 2 |
Global Payments
GPN
|
+$421M |
| 3 |
Eaton
ETN
|
+$415M |
| 4 |
Dell
DELL
|
+$391M |
| 5 |
Howmet Aerospace
HWM
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.82% |
| 2 | Technology | 16.67% |
| 3 | Industrials | 16.22% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Jiayin Group
JFIN
$67M
| $421K | ﹤0.01% |
67,362
| – | – |
2024 Q1
1 quarter
|
|
677
RingCentral
RNG
$6.32B
| $408K | ﹤0.01% |
+32,719
| New | +$1.05M |
2024 Q2
0 quarters
|
|
678
DELISTED
Pinstripes Holdings, Inc.
PNST
| $406K | ﹤0.01% |
147,484
| – | – |
2024 Q1
1 quarter
|
|
679
DELISTED
Denny's
DENN
| $399K | ﹤0.01% |
56,175
+34,620
| +161% | +$267K |
2024 Q1
1 quarter
|
|
680
RCM Technologies
RCMT
$270M
| $394K | ﹤0.01% |
21,066
| – | – |
2023 Q2
4 quarters
|
|
681
CareDx
CDNA
$3.31B
| $377K | ﹤0.01% |
+24,289
| New | +$294K |
2024 Q2
0 quarters
|
|
682
Caterpillar
CAT
$340B
| $375K | ﹤0.01% |
1,125
-296
| -21% | -$103K |
2018 Q3
23 quarters
|
|
683
Driven Brands
DRVN
$1.99B
| $370K | ﹤0.01% |
114,185
+6,118
| +6% | +$77.4K |
2022 Q4
6 quarters
|
|
684
nLIGHT
LASR
$1.96B
| $365K | ﹤0.01% |
33,412
+22,567
| +208% | +$274K |
2022 Q4
6 quarters
|
|
685
Star Holdings Shares of Beneficial Interest
STHO
$95.2M
| $349K | ﹤0.01% |
28,955
| – | – |
2023 Q2
4 quarters
|
|
686
Neighborhood Intelligence Inc
NXH
$183M
| $337K | ﹤0.01% |
28,361
-37,902
| -57% | -$673K |
2024 Q1
1 quarter
|
|
687
AstraZeneca
AZN
$257B
| $309K | ﹤0.01% |
1,973
-272
| -12% | -$40.9K |
2024 Q1
1 quarter
|
|
688
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $272K | ﹤0.01% |
309,310
+170,902
| +123% | +$352K |
2021 Q4
10 quarters
|
|
689
Thermo Fisher Scientific
TMO
$253B
| $261K | ﹤0.01% |
472
-334
| -41% | -$191K |
2021 Q2
12 quarters
|
|
690
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$311M
| $253K | ﹤0.01% |
+1,027
| New | +$340K |
2024 Q2
0 quarters
|
|
691
DELISTED
First Foundation Inc
FFWM
| $237K | ﹤0.01% |
36,110
+19,187
| +113% | +$118K |
2024 Q1
1 quarter
|
|
692
TechTarget
TTGT
$281M
| $228K | ﹤0.01% |
+7,324
| New | +$217K |
2024 Q2
0 quarters
|
|
693
Goodyear
GT
$1.26B
| $208K | ﹤0.01% |
53,848
-21,262
| -28% | -$260K |
2023 Q4
2 quarters
|
|
694
Argan
AGX
$5B
| $203K | ﹤0.01% |
+2,768
| New | +$181K |
2024 Q2
0 quarters
|
|
695
Here Group Ltd
HERE
$88.6M
| $162K | ﹤0.01% |
98,007
| – | – |
2024 Q1
1 quarter
|
|
696
Aqua Metals
AQMS
$5.92M
| $128K | ﹤0.01% |
2,003
-1,077
| -35% | -$98.6K |
2023 Q1
5 quarters
|
|
697
Fathom Holdings
FTHM
$6.78M
| $92.2K | ﹤0.01% |
+53,612
| New | +$89.2K |
2024 Q2
0 quarters
|
|
698
Compass
COMP
$7.12B
| $82.2K | ﹤0.01% |
22,838
-41,116
| -64% | -$151K |
2024 Q1
1 quarter
|
|
699
Lifecore Biomedical
LFCR
$243M
| $72.9K | ﹤0.01% |
14,212
-5,462
| -28% | -$32.3K |
2024 Q1
1 quarter
|
|
700
Lloyds Banking Group
LYG
$79B
| $30.9K | ﹤0.01% |
+10,248
| New | +$27.5K |
2024 Q2
0 quarters
|
|
Similar funds
Boston Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Boston Partners held 817 positions worth $80.5B, down 4.1% from $84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q2 2024 filing shows 51 new, 266 increased, 358 reduced and 117 closed positions. Its largest new stake was Honeywell: 1,930,615 shares worth $389M. The largest sale was Sanofi, an estimated $486M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q2 2024 buy was Honeywell: 1,930,615 shares worth $389M.
- Boston Partners added most to AbbVie in Q2 2024, an estimated $499M increase.
- Boston Partners's biggest Q2 2024 reduction was Sanofi, cutting an estimated $486M.
- Boston Partners fully exited Globe Life in Q2 2024, selling an estimated $243M.
- Boston Partners's ten largest holdings make up 14% of its $80.5B portfolio in Q2 2024.
- Boston Partners opened 51 new positions and closed 117 in Q2 2024.
- Boston Partners's portfolio value fell 4.1% quarter-over-quarter to $80.5B.
Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.